期刊文献+

脑尔康对AD模型小鼠脑内APP,Aβ表达的影响 被引量:8

Protective Effects of Naoerkang on AD Mice Induced by Chronic Al Toxicity Involved in Regulatting Protein Expression of APP and Aβ
原文传递
导出
摘要 目的:观察复方中药脑尔康对慢性铝中毒阿尔茨海默病(AD)模型小鼠学习记忆及脑内淀粉样前体蛋白(APP),β淀粉样蛋白(Aβ)表达的影响,探讨该药抗痴呆的分子机制。方法:60只昆明小鼠随机分为空白对照、模型、西药吡啦西坦、脑尔康高、中、低剂量6组,除空白组外,其余各组均采用氯化铝(AlCl3)溶液以100 mg.kg-1ip造模,空白组给予等量生理盐水ip,3个剂量脑尔康组给予脑尔康(34,17,8.5 g.kg-1.d-1)连续ig 50 d,吡啦西坦组给予吡啦西坦(10 g.L-1)ig,空白组和模型组给予等量生理盐水ig。采用跳台法检测AD模型小鼠学习记忆成绩,用免疫组织化学方法观察脑尔康对AD模型小鼠脑皮层及海马结构区域APP,Aβ表达的影响,对APP,Aβ阳性反应物质采用图像信号采集与分析系统进行灰度分析。结果:与对照组比较,模型组记忆潜伏期明显缩短(P<0.01),学习潜伏期明显延长(P<0.05),学习与记忆的错误次数明显增多(P<0.01);用药各组分别与模型组比较记忆潜伏期明显延长(P<0.01),学习潜伏期明显缩短(P<0.05),学习与记忆的错误次数明显减少(P<0.01)。各用药组模型小鼠脑内APP,Aβ的表达均不同程度减少(P<0.05或P<0.01);脑尔康3个剂量组比较存在明显量效关系。结论:脑尔康对慢性铝中毒AD模型具有显著的抗痴呆作用,其作用机制可能与调控APP,Aβ表达有关。 Objective: To investigate the protective effects of Naoerkang(NEK) on Alzheimer disease(AD) mince induced by chronic Al(AlCl3) toxicity involved in regulating protein expression of amyloid precursor protein(APP) and β-amyloid(Aβ).Method: Sixty male mice were randomly divided into normal control group,model group,piracetam group,low-dose NEK group,medium-dose NEK group,and high-dose NEK group,with 10 mice in each group,AlCl3(100 mg·kg-1) were injected into abdominal cavity in mice to establish AD model whereas the normal control mice were injected with same volume of saline for comparisom.The mice in the NEK groups were intragastrically treated respectively with high,medium and low dose(1.36,0.68,0.34 g·mL^-1) NEK for 50 days consecutively;piracetam(10 g·mL^-1) was intragastrically administered to mice in the piracetam group;and normal saline was applied in the control and model groups.Jumping stand was used to examine their abilities in learning and memory.The positive protein expression of APP and Aβ in cortex and hippocampal region of the mice in each group were detected by immunohistochemistry,and the results were analyzed by gray scale adopting Qwin550CW images and signals cllection and analysis system.Result: Compared with the control group,the Latent Period of memory was shortened significantly(P〈0.01),while that of learning had been prolonged obviously(P〈0.05)and the times of mistakes for learning and memory increased significantly(P〈0.01) for the mice of the model group.Compared with the model group,the Latent Period memory in the groups treatment with drug shortened significantly(P〈0.01),while that of learning had been prolonged obviously(P〈0.05)and the Frequency of Error for learning and memory had been increased evidently(P〈0.01).The expressions of APP,Aβ in cortex and hippocampus had been increased significantly(P〈0.05 orP〈0.01) for the mice of the model group,and it had shown a more obvious reduction campared with the group using Naoerkang(P〈0.01).Conclusion: Naoerkang can ameliorate the AD induced by Aβ,the mechanism maybe involve in regulating APP and Aβ.
出处 《中国实验方剂学杂志》 CAS 北大核心 2011年第24期140-143,共4页 Chinese Journal of Experimental Traditional Medical Formulae
基金 陕西省科技攻关计划项目[2007K16-07(5)]
关键词 脑尔康 阿尔茨海默病 淀粉样前体蛋白 Β淀粉样蛋白 抗痴呆 Naoerkang Alzheimer'disease amyloid precursor protein β-amyloid anti-dementia
  • 相关文献

参考文献8

  • 1李玺,张雪飞,乔成林,张智燕.脑尔康对老年痴呆小鼠脑内胆碱酯酶活性及神经元的影响(英文)[J].中国临床康复,2003,7(31):4222-4223. 被引量:5
  • 2李玺,王建军,乔成林,聂丹丽.脑尔康对小鼠学习记忆障碍的改善作用[J].西安医科大学学报,1999,20(1):126-127. 被引量:3
  • 3Glenner G G, Wong C W. Alzheimer’s disease and Down’s syndrome: sharing of a unique cerebrovascular amyloid fibril protein[J]. Biochem Biophys Res Commun, 1984,122:1131.
  • 4Nelson P T, Jicha G A, Schmitt F A,et al. Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity[J].J Neuropathol Exp Neurol, 2007,66(12):1136.
  • 5D\'Amelio M, Cavallucci V, Middei S,et al. Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer\'s disease[J]. Nat Neurosci, 2011, 14(1):69.
  • 6Lee Y J, Han S B, Nam S Y,et al.Inflammation and Alzheimer\'s disease[J].Arch Pharm Res, 2010,33(10):1539.
  • 7Manolopoulos K N, Klotz L O, Korsten P,et al.Linking Alzheimer\'s disease to insulin resistance: the FoxO response to oxidative stress[J].Mol Psyc Hiatry,2010,15(11):1046.
  • 8Leinonen V, Koivisto A M, Savolainen S, et al.Amyloid and tau proteins in cortical brain biopsy and Alzheimer\'s disease[J]. Ann Neurol, 2010,68(4):446.

二级参考文献10

  • 1刘孟渊,刘惠纯.益智中草药的研究概况[J].中国中西医结合杂志,1995,15(1):59-61. 被引量:31
  • 2陈奇.中药药理研究方法学(第1版)[M].北京:人民卫生出版社,1996.992-1011.
  • 3陈可冀,新编抗衰老中药学,1998年,418页
  • 4陈奇,中药药理研究方法学,1996年,894页
  • 5刘孟洲,中国中西医结合杂志,1995年,15卷,1期,59页
  • 6阴健,中药现代研究与临床应用,1993年,1页
  • 7李杰芳,中药新药与临床药理,1992年,8卷,5期,22页
  • 8李仪奎,中药药理实验方法学,1991年,36页
  • 9K. Herholz,B. Bauer,K. Wienhard,L. Kracht,R. Mielke,O. Lenz,T. Strotmann,W.-D. Heiss. In-vivo measurements of regional acetylcholine esterase activity in degenerative dementia: comparison with blood flow and glucose metabolism[J] 2000,Journal of Neural Transmission(12):1457~1468
  • 10李杰芬.日本对中药治疗老年人痴呆的研究[J].中药新药与临床药理,1992,3(2):45-48. 被引量:6

共引文献5

同被引文献128

引证文献8

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部